NewsBenzinga애브엑시타이드, 토요일 발표된 3상 LUCIDITY 시험에서 위절제술 후 저혈당증 1차 평가 지표 충족···치료 관련 중대한 이상반응 없이 위약군 대비 2/3단계 사건 발생률 주당 0.55건 대 1.24건 애브엑시타이드, 토요일 발표된 3상 LUCIDITY 시험에서 위절제술 후 저혈당증 1차 평가 지표 충족···치료 관련 중대한 이상반응 없이 위약군 대비 2/3단계 사건 발생률 주당 0.55건 대 1.24건 Benzinga 2026.11.16 05:33 (GMT+0) Open on Benzinga Other news South Korean Lawmaker Proposes Virtual Asset AML Bill, Exchanges Face Fines of Up to 100 Million Won Mark Carney Warns Canada Could Turn to China for Autos if Trade Talks With Trump Administration Fail: ‘Not Leverage. But Action, Reaction’ Italian Robotics Startup Mosaico Raises €7.5 Million Seed Round Ryan Cohen Wants Someone Who Can ‘Move Fast’ and ‘Own Results’ at GameStop as CEO Looks to Build His Next Big Move: Here’s How You Can Apply Are Wall Street Analysts Bullish on Eversource Energy Stock? Reported Saturday, Avexitide Meets Phase 3 LUCIDITY Primary Endpoint In Post-Bariatric Hypoglycemia, Cutting Level 2/3 Events 0.55 Per Week Versus 1.24 For Placebo, With No Treatment-Related Serious Adverse Events
Mark Carney Warns Canada Could Turn to China for Autos if Trade Talks With Trump Administration Fail: ‘Not Leverage. But Action, Reaction’
Ryan Cohen Wants Someone Who Can ‘Move Fast’ and ‘Own Results’ at GameStop as CEO Looks to Build His Next Big Move: Here’s How You Can Apply
Reported Saturday, Avexitide Meets Phase 3 LUCIDITY Primary Endpoint In Post-Bariatric Hypoglycemia, Cutting Level 2/3 Events 0.55 Per Week Versus 1.24 For Placebo, With No Treatment-Related Serious Adverse Events